Arun Chumber

4PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 28, 2026
Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

|Jan 20, 2026
Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells.

Tony Li, Arielle Ilano, Marcel Arias-Badia

|Apr 01, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response.

Miho Tanaka, Lotus Lum, Kenneth H Hu

|Mar 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer.

Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele

Pageof 1